Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Atherosclerosis

Retrieve available abstracts of 46 articles:
HTML format
Text format



Single Articles


    November 2017
  1. CHRISTODOULOU E, Kadoglou NPE, Stasinopoulou M, Konstandi OA, et al
    Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals.
    Atherosclerosis. 2017 Nov 1. pii: S0021-9150(17)31370.
    PubMed     Text format     Abstract available


    October 2017
  2. GANJALI S, Dallinga-Thie GM, Simental-Mendia LE, Banach M, et al
    HDL functionality in type 1 diabetes.
    Atherosclerosis. 2017;267:99-109.
    PubMed     Text format     Abstract available


    September 2017
  3. MARCADENTI A, Fuchs FD, Moreira LB, Gus M, et al
    Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference.
    Atherosclerosis. 2017;266:145-150.
    PubMed     Text format     Abstract available


    August 2017
  4. TAMURA K, Haruhara K, Azushima K, Tokita Y, et al
    Possible impact of electronegative LDL on atherosclerosis in type 2 diabetes.
    Atherosclerosis. 2017 Aug 26. pii: S0021-9150(17)31240.
    PubMed     Text format    


  5. CHU LM, Liu CC, Yeh CC, Chang YC, et al
    Increased diabetes risk and interaction with social and medical events in patients upon stroke: Two nationwide studies.
    Atherosclerosis. 2017;265:87-92.
    PubMed     Text format     Abstract available


  6. SCHMIDT N, Schmidt B, Dressel A, Gergei I, et al
    Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.
    Atherosclerosis. 2017;266:24-30.
    PubMed     Text format     Abstract available


    July 2017
  7. ESTRUCH M, Minambres I, Sanchez-Quesada JL, Soler M, et al
    Increased inflammatory effect of electronegative LDL and decreased protection by HDL in type 2 diabetic patients.
    Atherosclerosis. 2017 Jul 13. pii: S0021-9150(17)31190.
    PubMed     Text format     Abstract available


  8. PRICE AH, Weir CJ, Welsh P, McLachlan S, et al
    Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.
    Atherosclerosis. 2017;264:67-73.
    PubMed     Text format     Abstract available


  9. WANNAMETHEE SG, Welsh P, Papacosta O, Ellins EA, et al
    Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes.
    Atherosclerosis. 2017;264:36-43.
    PubMed     Text format     Abstract available


    June 2017
  10. HAGENSEN MK, Mortensen MB, Kjolby M, Stillits NL, et al
    Reply to "Bioinformatics analysis in type 1 diabetes increases retention of low-density lipoprotein in the atherosclerosis-prone area of the murine aorta".
    Atherosclerosis. 2017 Jun 30. pii: S0021-9150(17)31175.
    PubMed     Text format    


  11. LI C, Liu X, Liu H, Zhao Q, et al
    Bioinformatics analysis in type 1 diabetes increases retention of low-density lipoprotein in the atherosclerosis-prone area of the murine aorta.
    Atherosclerosis. 2017 Jun 10. pii: S0021-9150(17)30274.
    PubMed     Text format    


    May 2017
  12. SHIU SW, Wong Y, Tan KC
    Pre-beta1 HDL in type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:24-28.
    PubMed     Text format     Abstract available


  13. HAGENSEN MK, Mortensen MB, Kjolby M, Stillits NL, et al
    Type 1 diabetes increases retention of low-density lipoprotein in the atherosclerosis-prone area of the murine aorta.
    Atherosclerosis. 2017;263:7-14.
    PubMed     Text format     Abstract available


    March 2017
  14. SANTOS IS, Bittencourt MS, Goulart AC, Schmidt MI, et al
    Insulin resistance is associated with carotid intima-media thickness in non-diabetic subjects. A cross-sectional analysis of the ELSA-Brasil cohort baseline.
    Atherosclerosis. 2017;260:34-40.
    PubMed     Text format     Abstract available


  15. LAMACCHIA O, Fontana A, Pacilli A, Copetti M, et al
    On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus.
    Atherosclerosis. 2017;260:20-26.
    PubMed     Text format     Abstract available


    February 2017
  16. FELDMAN DI, Valero-Elizondo J, Salami JA, Rana JS, et al
    Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS).
    Atherosclerosis. 2017;258:79-83.
    PubMed     Text format     Abstract available


    January 2017
  17. MAILE LA, Busby WH, Xi G, Gollahan KP, et al
    An anti-alphaVbeta3 antibody inhibits coronary artery atherosclerosis in diabetic pigs.
    Atherosclerosis. 2017;258:40-50.
    PubMed     Text format     Abstract available


  18. MOH MC, Sum CF, Tavintharan S, Ang K, et al
    Baseline predictors of aortic stiffness progression among multi-ethnic Asians with type 2 diabetes.
    Atherosclerosis. 2017;260:102-109.
    PubMed     Text format     Abstract available


    December 2016
  19. LEE DH, Chun EJ, Hur JH, Min SH, et al
    Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes.
    Atherosclerosis. 2016;257:47-54.
    PubMed     Text format     Abstract available


  20. CHEN J, Zhang J, Yang J, Xu L, et al
    Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
    Atherosclerosis. 2016;257:152-163.
    PubMed     Text format     Abstract available


  21. SCHOFIELD JD, Steiner R, Liu Y, Hobkirk J, et al
    Sphingolipids and deoxysphingolipids in diabetes.
    Atherosclerosis. 2016;255:4.
    PubMed     Text format    


  22. BANERJEE P, Appleton M, Bowron A, Bartlett K, et al
    Ceramides in diabetes.
    Atherosclerosis. 2016;255:1-2.
    PubMed     Text format    


    November 2016
  23. LANGSTED A, Freiberg JJ, Nordestgaard BG
    Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004-2014.
    Atherosclerosis. 2016;257:9-15.
    PubMed     Text format     Abstract available


  24. SCICALI R, Giral P, Gallo A, Di Pino A, et al
    HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
    Atherosclerosis. 2016;255:102-108.
    PubMed     Text format     Abstract available


  25. NAKANISHI R, Ceponiene I, Osawa K, Luo Y, et al
    Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study.
    Atherosclerosis. 2016;255:73-79.
    PubMed     Text format     Abstract available


    September 2016
  26. BERK KA, Vongpromek R, Jiang M, Schneider WJ, et al
    Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss.
    Atherosclerosis. 2016;254:67-72.
    PubMed     Text format     Abstract available


  27. AFARIDEH M, Aryan Z, Ghajar A, Noshad S, et al
    Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes.
    Atherosclerosis. 2016;254:42-51.
    PubMed     Text format     Abstract available


    August 2016
  28. KIANOUSH S, Blaha MJ
    Early interventions for optimal control of prediabetes and diabetes: Critical to prevent cardiovascular disease?
    Atherosclerosis. 2016 Aug 28. pii: S0021-9150(16)31307.
    PubMed     Text format    


  29. HEFFERNAN KS
    Carotid artery stiffness and cognitive function in adults with and without type 2 diabetes: Extracranial contribution to an intracranial problem?
    Atherosclerosis. 2016 Aug 27. pii: S0021-9150(16)31297.
    PubMed     Text format    


  30. FIORENTINO TV, Sesti F, Andreozzi F, Pedace E, et al
    One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden.
    Atherosclerosis. 2016;253:61-69.
    PubMed     Text format     Abstract available


  31. IKEDA N, Hara H, Hiroi Y, Nakamura M, et al
    Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
    Atherosclerosis. 2016;253:1-6.
    PubMed     Text format     Abstract available


    July 2016
  32. GEIJSELAERS SL, Sep SJ, Schram MT, van Boxtel MP, et al
    Carotid stiffness is associated with impairment of cognitive performance in individuals with and without type 2 diabetes. The Maastricht Study.
    Atherosclerosis. 2016 Jul 22. pii: S0021-9150(16)31213.
    PubMed     Text format     Abstract available


  33. WYCHERLEY TP, Thompson CH, Buckley JD, Luscombe-Marsh ND, et al
    Long-term effects of weight loss with a very-low carbohydrate, low saturated fat diet on flow mediated dilatation in patients with type 2 diabetes: A randomised controlled trial.
    Atherosclerosis. 2016;252:28-31.
    PubMed     Text format     Abstract available


  34. THEN C, Rottenkolber M, Lechner A, Meisinger C, et al
    Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study.
    Atherosclerosis. 2016;252:88-96.
    PubMed     Text format     Abstract available


    June 2016
  35. BEN NASR M, Fiorina P
    CXCR4 antagonism overcomes diabetic stem cell mobilopathy.
    Atherosclerosis. 2016 Jun 23. pii: S0021-9150(16)30268.
    PubMed     Text format    


  36. BORRADAILE N, Le Goff W
    Lipidomic approach provides new clues toward solving the mystery of accelerated atherosclerosis in diabetes.
    Atherosclerosis. 2016 Jun 11. pii: S0021-9150(16)30247.
    PubMed     Text format    


    May 2016
  37. CAPPELLARI R, D'Anna M, Avogaro A, Fadini GP, et al
    Plerixafor improves the endothelial health balance. The effect of diabetes analysed by polychromatic flow cytometry.
    Atherosclerosis. 2016 May 20. pii: S0021-9150(16)30205.
    PubMed     Text format     Abstract available


  38. NARDIN M, Verdoia M, Schaffer A, Barbieri L, et al
    Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.
    Atherosclerosis. 2016;250:114-121.
    PubMed     Text format     Abstract available


  39. MENEGAUT L, Masson D, Abello N, Denimal D, et al
    Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
    Atherosclerosis. 2016 May 4. pii: S0021-9150(16)30164.
    PubMed     Text format     Abstract available


  40. KIEC-WILK B, Matejko B, Razny U, Stankiewicz M, et al
    Hypoglycemic episodes are associated with inflammatory status in patients with type 1 diabetes mellitus.
    Atherosclerosis. 2016 May 3. pii: S0021-9150(16)30162.
    PubMed     Text format     Abstract available


  41. ARONER SA, St-Jules DE, Mukamal KJ, Katz R, et al
    Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2016;248:224-9.
    PubMed     Text format     Abstract available


  42. KIM SA, Park SH, Jo SH, Park KH, et al
    Alterations of carotid arterial mechanics preceding the wall thickening in patients with hypertension.
    Atherosclerosis. 2016;248:84-90.
    PubMed     Text format     Abstract available


  43. PAN L, Yang Z, Wu Y, Yin RX, et al
    The prevalence, awareness, treatment and control of dyslipidemia among adults in China.
    Atherosclerosis. 2016;248:2-9.
    PubMed     Text format     Abstract available


    April 2016
  44. ORTEGA MORENO L, Lamacchia O, Fontana A, Copetti M, et al
    The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: Evidence of synergism with abdominal adiposity.
    Atherosclerosis. 2016;250:23-29.
    PubMed     Text format     Abstract available


  45. LANDMAN GW, Kleefstra N, Groenier KH, Bakker SJ, et al
    Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Atherosclerosis. 2016;250:46-51.
    PubMed     Text format     Abstract available


  46. WILLIAMS KJ, Wu X
    Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward.
    Atherosclerosis. 2016;247:225-82.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: